ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Volume 21, 11 Issues, 2021

Open Access Funding Promote Your Article

Current Cancer Drug Targets

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Aims & Scope Abstracted/Indexed in

Ranking and Category:

ONCOLOGY 140^th of 222

Submit Abstracts / Manuscripts Online Animated Abstract Submission

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

View Full Editorial Board

Personal Subscription

Current: 2.912
5 - Year: 2.947

Abstracted/Indexed in

Announcements

Endorsement(s)

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets."

Paul Workman
CRC Centre for Cancer Therapeutics, England

Authors' Comments

“"I would like to express my sincere thanks for the services by Bentham Science.
I'm really happy with my submission in your Journal and hope that I will able to continue submitting manuscripts to your journal"”

Saeed Samarghandian
(Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran)

Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery promotion: free to download

Volume:12 Issue: 1
Pp: 1-13
G. Kauselmann, A. Dopazo and W. Link
DOI: 10.2174/156800912798888947

Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma promotion: free to download

Volume:12 Issue: 1
Pp: 14-22
H. Miyamoto, Y. Zheng and K. Izumi
DOI: 10.2174/156800912798888965

The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis promotion: free to download

Volume:12 Issue: 1
Pp: 23-43
A. Amini, S. Masoumi Moghaddam, D. L. Morris and M. H. Pourgholami
DOI: 10.2174/156800912798888956

Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations promotion: free to download

Volume:12 Issue: 1
Pp: 44-50
C. F. Singer, P. Zabkova, C. Rappaport, D. Muhr, G. Pfeiler, D. Gschwantler-Kaulich, A. Fink-Retter, C. Staudigl, I. Walter, G. Hudelist, A.-C. Spiess and E. Kubista
DOI: 10.2174/156800912798888938

The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells promotion: free to download

Volume:12 Issue: 1
Pp: 51-63
H. Herrmann, M. Kneidinger, S. Cerny-Reiterer, T. Rulicke, M. Willmann, K. V. Gleixner, K. Blatt, G. Hormann, B. Peter, P. Samorapoompichit, W. Pickl, G. Y. Bharate, M. Mayerhofer, W. R. Sperr, H. Maeda and P. Valent
DOI: 10.2174/156800912798888992

Targeting Urokinase and the Transferrin Receptor with Novel, Anti-Mitotic N-Alkylisatin Cytotoxin Conjugates Causes Selective Cancer Cell Death and Reduces Tumor Growth promotion: free to download

Volume:12 Issue: 1
Pp: 64-73
K. L. Vine, V. Indira Chandran, J. M. Locke, L. Matesic, J. Lee, D. Skropeta, J. B. Bremner and M. Ranson
DOI: 10.2174/156800912798888983

Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells promotion: free to download

Volume:12 Issue: 1
Pp: 74-84
Y.-W. Zhang, D.-L. Yan, W. Wang, H.-W. Zhao, X. Lu, J.-Z. Wu and J.-R. Zhou
DOI: 10.2174/156800912798888974